Part detail
Diltiazem Extended Release Capsules Usp
228257803NSN6505-01-353-9845CAGE56287
Diltiazem Extended Release Capsules Usp
Detailed description
228257803 procurement notes
Diltiazem Extended Release Capsules Usp
Specifications
Reference data
Multi-line procurement
Sourcing more than one part?
Upload a bill of materials (BOM) or paste a list of part numbers — every line bundles into a single RFQ. No checkout, no payment.
Compliance
- AS9120:2025· Aerospace QMS
- ISO 9001:2015· Quality Management
- FAA AC 00-56B· Voluntary Industry Distributor Accreditation
- U.S. ONLY· Fulfillment
Characteristics Data of NSN 6505-01-353-9845, 6505013539845
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 240.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | DILTIAZEM EXTENDED-RELEASE CAPSULES USP 240MG 30S BT |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 30.000 |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| THPE | THERAPEUTIC EQUIVALENT | TO CARDIZEM CD BY MARION MERRELL DOW |